<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33541434</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2051-5960</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>Acta neuropathologica communications</Title><ISOAbbreviation>Acta Neuropathol Commun</ISOAbbreviation></Journal><ArticleTitle>Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALS.</ArticleTitle><Pagination><StartPage>21</StartPage><MedlinePgn>21</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40478-020-01116-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive fatal neurodegenerative disease that affects motoneurons. Mutations in superoxide dismutase 1 (SOD1) have been described as a causative genetic factor for ALS. Mice overexpressing ALS-linked mutant SOD1 develop ALS symptoms accompanied by histopathological alterations and protein aggregation. The protein disulfide isomerase family member ERp57 is one of the main up-regulated proteins in tissue of ALS patients and mutant SOD1 mice, whereas point mutations in ERp57 were described as possible risk factors to develop the disease. ERp57 catalyzes disulfide bond formation and isomerization in the endoplasmic reticulum (ER), constituting a central component of protein quality control mechanisms. However, the actual contribution of ERp57 to ALS pathogenesis remained to be defined. Here, we studied the consequences of overexpressing ERp57 in experimental ALS using mutant SOD1 mice. Double transgenic SOD1<sup>G93A</sup>/ERp57<sup>WT</sup> animals presented delayed deterioration of electrophysiological activity and maintained muscle innervation compared to single transgenic SOD1<sup>G93A</sup> littermates at early-symptomatic stage, along with improved motor performance without affecting survival. The overexpression of ERp57 reduced mutant SOD1 aggregation, but only at disease end-stage, dissociating its role as an anti-aggregation factor from the protection of neuromuscular junctions. Instead, proteomic analysis revealed that the neuroprotective effects of ERp57 overexpression correlated with increased levels of synaptic and actin cytoskeleton proteins in the spinal cord. Taken together, our results suggest that ERp57 operates as a disease modifier at early stages by maintaining motoneuron connectivity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rozas</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuromuscular Studies Laboratory (NeSt Lab), Department of Cell Biology, Faculty of Biological Sciences, Center for Advanced Microscopy (CMA Bio-Bio), Universidad de Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Traub</LastName><ForeName>Francisca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez</LastName><ForeName>Viviana</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neuromuscular Studies Laboratory (NeSt Lab), Department of Cell Biology, Faculty of Biological Sciences, Center for Advanced Microscopy (CMA Bio-Bio), Universidad de Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becerra</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojeda</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojeda</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuromuscular Studies Laboratory (NeSt Lab), Department of Cell Biology, Faculty of Biological Sciences, Center for Advanced Microscopy (CMA Bio-Bio), Universidad de Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Madison T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mella</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Neuromuscular Studies Laboratory (NeSt Lab), Department of Cell Biology, Faculty of Biological Sciences, Center for Advanced Microscopy (CMA Bio-Bio), Universidad de Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plate</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henr&#xed;quez</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Neuromuscular Studies Laboratory (NeSt Lab), Department of Cell Biology, Faculty of Biological Sciences, Center for Advanced Microscopy (CMA Bio-Bio), Universidad de Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hetz</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile. chetz@uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile. chetz@uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile. chetz@uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA. chetz@uchile.cl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medinas</LastName><ForeName>Danilo B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Biomedical Neuroscience Institute, Faculty of Medicine, University of Chile, Independencia 1027, P.O. Box 70086, Santiago, Chile. dmedinas@med.uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Geroscience, Brain Health and Metabolism, Santiago, Chile. dmedinas@med.uchile.cl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, University of Chile, Santiago, Chile. dmedinas@med.uchile.cl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Neuropathol Commun</MedlineTA><NlmUniqueID>101610673</NlmUniqueID><ISSNLinking>2051-5960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1</RegistryNumber><NameOfSubstance UI="C513195">Pdia3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.4.1</RegistryNumber><NameOfSubstance UI="D019704">Protein Disulfide-Isomerases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009121" MajorTopicYN="N">Muscle Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019704" MajorTopicYN="N">Protein Disulfide-Isomerases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">ERp57</Keyword><Keyword MajorTopicYN="N">Mutant SOD1</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>5</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33541434</ArticleId><ArticleId IdType="pmc">PMC7863244</ArticleId><ArticleId IdType="doi">10.1186/s40478-020-01116-z</ArticleId><ArticleId IdType="pii">10.1186/s40478-020-01116-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peters OM, Ghasemi M, Brown RH. Emerging mechanisms of molecular pathology in ALS. J Clin Invest. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, den Berg LH, Veldink JH, Vucic S, Kiernan MC. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander GM, Erwin KL, Byers N, Deitch JS, Augelli BJ, Blankenhorn EP, Heiman-Patterson TD. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Mol Brain Res. 2004;130:7&#x2013;15. doi: 10.1016/j.molbrainres.2004.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molbrainres.2004.07.002</ArticleId><ArticleId IdType="pubmed">15519671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Canto DMC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science (80-) 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas DB, Rozas P, Traub FM, Woehlbier U, Brown RH, Bosco DA, Hetz C. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci. 2018;115:8209&#x2013;8214. doi: 10.1073/PNAS.1801109115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, Morfini G, Karabacak MN, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien J-P, Brady ST, Robert RH., Jr Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, Tortarolo M, Salmona M, Gianazza E, Bendotti C, Bonetto V. Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun. 2007;353:719&#x2013;725. doi: 10.1016/j.bbrc.2006.12.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.12.075</ArticleId><ArticleId IdType="pubmed">17196550</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin J, Farg M, Walker A, McLean C, Tomas D, Horne M. Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis. 2008;30:400&#x2013;407. doi: 10.1016/j.nbd.2008.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.02.009</ArticleId><ArticleId IdType="pubmed">18440237</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Shadfar S, Perri ER, Ragagnin AMG, Piattoni CV, Fogol&#xed;n MB, Yuan KC, Shahhyedari H, Don EK, Thomas CJ, Hong Y, Comini MA, Laird AS, Spencer DM, Atkin JD. The redox activity of protein disulphide isomerase (PDI) inhibits ALS phenotypes in cellular and zebrafish models. iScience. 2020;23:101097. doi: 10.1016/j.isci.2020.101097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101097</ArticleId><ArticleId IdType="pmc">PMC7240177</ArticleId><ArticleId IdType="pubmed">32446203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo A, Brown R, Glimcher L. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306. doi: 10.1101/gad.1830709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1830709</ArticleId><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Pozzi S, Pignataro M, Lauranzano E, Spano G, Garbelli S, Mantovani S, Marinou K, Papetti L, Monteforte M, Torri V, Paris L, Bazzoni G, Lunetta C, Corbo M, Mora G, Bendotti C, Bonetto V. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS ONE. 2011;6:e25545. doi: 10.1371/journal.pone.0025545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025545</ArticleId><ArticleId IdType="pmc">PMC3187793</ArticleId><ArticleId IdType="pubmed">21998667</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Perez P, Woehlbier U, Chian R-JJ, Sapp P, Rouleau GA, Leblond CS, Daoud H, Dion PA, Landers JE, Hetz C, Brown RH. Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients. Gene. 2015;566:158&#x2013;165. doi: 10.1016/j.gene.2015.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.04.035</ArticleId><ArticleId IdType="pmc">PMC5553116</ArticleId><ArticleId IdType="pubmed">25913742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CT, Morris AG, Frampton J, Smith B, Shaw CE, de Belleroche J. Association studies indicate that protein disulfide isomerase is a risk factor in amyotrophic lateral sclerosis. Free Radic Biol Med. 2013;58:81&#x2013;86. doi: 10.1016/j.freeradbiomed.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.01.001</ArticleId><ArticleId IdType="pubmed">23337974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Guo Z. Polymorphisms in protein disulfide isomerase are associated with sporadic amyotrophic lateral sclerosis in the Chinese Han population. Int J Neurosci. 2015;126:1&#x2013;5. doi: 10.3109/00207454.2015.1050098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2015.1050098</ArticleId><ArticleId IdType="pubmed">26000911</ArticleId></ArticleIdList></Reference><Reference><Citation>Woehlbier U, Colombo A, Saaranen MJ, P&#xe9;rez V, Ojeda J, Bustos FJ, Andreu CI, Torres M, Valenzuela V, Medinas DB, Rozas P, Vidal RL, Lopez-Gonzalez R, Salameh J, Fernandez-Collemann S, Mu&#xf1;oz N, Matus S, Armisen R, Sagredo A, Palma K, Irrazabal T, Almeida S, Gonzalez-Perez P, Campero M, Gao F-BB, Henny P, van Zundert B, Ruddock LW, Concha ML, Henriquez JP, Brown RH, Hetz C. ALS-linked protein disulfide isomerase variants cause motor dysfunction. EMBO J. 2016;35:845&#x2013;865. doi: 10.15252/embj.201592224.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592224</ArticleId><ArticleId IdType="pmc">PMC4972141</ArticleId><ArticleId IdType="pubmed">26869642</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Atkin JD. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;649. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Jagaraj CJ, Vidal M, Ragagnin AMG, Perri ER, Konopka A, Toth R, Galper J, Blair IP, Thomas CJ, Walker AK, Yang S, Spencer DM, Atkin JD. ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis. Hum Mol Genet. 2018 doi: 10.1093/hmg/ddy041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy041</ArticleId><ArticleId IdType="pubmed">29409023</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13:477&#x2013;491. doi: 10.1038/nrneurol.2017.99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.99</ArticleId><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa S, Abdulrahman B, Abdelaziz DH, Lu L, Ben AM, Schatzl HM. Overexpression of quality control proteins reduces prion conversion in prion-infected cells. J Biol Chem. 2018;293:16069&#x2013;16082. doi: 10.1074/jbc.RA118.002754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.002754</ArticleId><ArticleId IdType="pmc">PMC6187620</ArticleId><ArticleId IdType="pubmed">30154245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Russelakis-Carneiro M, W&#xe4;lchli S, Carboni S, Vial-Knecht E, Maundrell K, Castilla J, Soto C. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci. 2005;25:2793&#x2013;2802. doi: 10.1523/JNEUROSCI.4090-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4090-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725139</ArticleId><ArticleId IdType="pubmed">15772339</ArticleId></ArticleIdList></Reference><Reference><Citation>Achilli F, Boyle S, Kieran D, Chia R, Hafezparast M, Martin JE, Schiavo G, Greensmith L, Bickmore W, Fisher EMC. The SOD1 transgene in the G93A mouse model of amyotrophic lateral sclerosis lies on distal mouse chromosome 12. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6:111&#x2013;114. doi: 10.1080/14660820510035351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510035351</ArticleId><ArticleId IdType="pubmed">16036435</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres M, Medinas DB, Matamala JMM, Woehlbier U, Cornejo VHH, Solda T, Andreu C, Rozas P, Matus S, Mu&#xf1;oz N, Vergara C, Cartier L, Soto C, Molinari M, Hetz C. The protein-disulfide isomerase ERp57 regulates the steady-state levels of the prion protein. J Biol Chem. 2015;290:23631&#x2013;23645. doi: 10.1074/jbc.M114.635565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.635565</ArticleId><ArticleId IdType="pmc">PMC4583042</ArticleId><ArticleId IdType="pubmed">26170458</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo V, O&#xf1;ate M, Woehlbier U, Rozas P, Andreu C, Medinas D, Vald&#xe9;s P, Osorio F, Mercado G, Vidal RL, Kerr B, Court FA, Hetz C. Functional role of the disulfide isomerase ERp57 in axonal regeneration. PLoS ONE. 2015;10:e0136620. doi: 10.1371/journal.pone.0136620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0136620</ArticleId><ArticleId IdType="pmc">PMC4567344</ArticleId><ArticleId IdType="pubmed">26361352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler J-P, Mead R, Niessen HG, Petri S, Pradat P-F, Robberecht W, Ruegg M, Schwalenst&#xf6;cker B, Stiller D, van den Berg L, Vieira F, von Horsten S. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler. 2010;11:38&#x2013;45. doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Osta R, Navarro X. Presymptomatic electrophysiological tests predict clinical onset and survival in SOD1G93A ALS mice. Muscle Nerve. 2014;50:943&#x2013;949. doi: 10.1002/mus.24237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24237</ArticleId><ArticleId IdType="pubmed">24619579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Burgess RW, Gillingwater TH, Cader MZ. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles. J Neurosci Methods. 2014;227:159&#x2013;165. doi: 10.1016/J.JNEUMETH.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNEUMETH.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC4120659</ArticleId><ArticleId IdType="pubmed">24530702</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RA, Reich CD, Dissanayake KN, Kristmundsdottir F, Findlater GS, Ribchester RR, Simmen MW, Gillingwater TH. NMJ-morph reveals principal components of synaptic morphology influencing structure&#x2013;function relationships at the neuromuscular junction. Open Biol. 2016;6:160240. doi: 10.1098/rsob.160240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.160240</ArticleId><ArticleId IdType="pmc">PMC5204123</ArticleId><ArticleId IdType="pubmed">27927794</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Atkin JD, Farg MA, Da WZ, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci. 2005;25:108&#x2013;117. doi: 10.1523/JNEUROSCI.4253-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4253-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725218</ArticleId><ArticleId IdType="pubmed">15634772</ArticleId></ArticleIdList></Reference><Reference><Citation>Plate L, Cooley CB, Chen JJ, Paxman RJ, Gallagher CM, Madoux F, Genereux JC, Dobbs W, Garza D, Spicer TP, Scampavia L, Brown SJ, Rosen H, Powers ET, Walter P, Hodder P, Luke Wiseman R, Kelly JW. Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation. Elife. 2016;5:e15550. doi: 10.7554/eLife.15550.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.15550</ArticleId><ArticleId IdType="pmc">PMC4954754</ArticleId><ArticleId IdType="pubmed">27435961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryno LM, Genereux JC, Naito T, Morimoto RI, Powers ET, Shoulders MD, Wiseman RL. Characterizing the altered cellular proteome induced by the stress-independent activation of heat shock factor 1. ACS Chem Biol. 2014;9:1273&#x2013;1283. doi: 10.1021/cb500062n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb500062n</ArticleId><ArticleId IdType="pmc">PMC4076015</ArticleId><ArticleId IdType="pubmed">24689980</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto C, C&#xe1;rdenas P, Osses N, Henr&#xed;quez JP. Characterization of Wnt/&#x3b2;-catenin and BMP/Smad signaling pathways in an in vitro model of amyotrophic lateral sclerosis. Front Cell Neurosci. 2013;7:239. doi: 10.3389/fncel.2013.00239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00239</ArticleId><ArticleId IdType="pmc">PMC3847560</ArticleId><ArticleId IdType="pubmed">24348333</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo GG, Patel K, Kumar V, Shah M, Fried VA, Etlinger JD, Sehgal PB. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J Interf Cytokine Res. 2002;22:555&#x2013;563. doi: 10.1089/10799900252982034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/10799900252982034</ArticleId><ArticleId IdType="pubmed">12060494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H, Almer G, Yamashita S, Gu&#xe9;gan C, Nagai M, Xu Z, Sosunov A, McKhann G, Przedborski S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc Natl Acad Sci U S A. 2006;103:6025&#x2013;6030. doi: 10.1073/pnas.0509227103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509227103</ArticleId><ArticleId IdType="pmc">PMC1458691</ArticleId><ArticleId IdType="pubmed">16595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien J-P. The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 2008;22:2476&#x2013;2487. doi: 10.1096/fj.07-092783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.07-092783</ArticleId><ArticleId IdType="pubmed">18337461</ArticleId></ArticleIdList></Reference><Reference><Citation>Okado-Matsumoto A, Fridovich I. Subcellular distribution of superoxide dismutases (SOD) in rat liver. Cu, Zn-SOD in mitochondria. J Biol Chem. 2001;276:38388&#x2013;38393. doi: 10.1074/jbc.M105395200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M105395200</ArticleId><ArticleId IdType="pubmed">11507097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP. Neuroblastoma &#xd7; spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis. 2002;10:128&#x2013;138. doi: 10.1006/nbdi.2002.0498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0498</ArticleId><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2000;97:12571&#x2013;12576. doi: 10.1073/pnas.220417997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220417997</ArticleId><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Fu R, Deng HX, Siddique T, O&#x2019;Halloran TV. Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc Natl Acad Sci U S A. 2006;103:7148&#x2013;7153. doi: 10.1073/pnas.0602048103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602048103</ArticleId><ArticleId IdType="pmc">PMC1447524</ArticleId><ArticleId IdType="pubmed">16636274</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Graffmo KS, Andersen PM, Br&#xe4;nnstr&#xf6;m T, Lindberg M, Oliveberg M, Marklund SL. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain. 2006;129:451&#x2013;464. doi: 10.1093/brain/awh704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh704</ArticleId><ArticleId IdType="pubmed">16330499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc Natl Acad Sci U S A. 2016;113:E8316&#x2013;E8325. doi: 10.1073/pnas.1605210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan A, Spiller KJ, Towne C, Kanning KC, Choe GT, Geber A, Akay T, Aebischer P, Henderson CE. Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron. 2014;81:333&#x2013;348. doi: 10.1016/j.neuron.2013.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.009</ArticleId><ArticleId IdType="pmc">PMC6015650</ArticleId><ArticleId IdType="pubmed">24462097</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley LH, Nijssen J, Frost-Nylen J, Hedlund E. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. J Comp Neurol. 2016;524:1424&#x2013;1442. doi: 10.1002/cne.23917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23917</ArticleId><ArticleId IdType="pmc">PMC5063101</ArticleId><ArticleId IdType="pubmed">26502195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewcock JW, Genoud N, Lettieri K, Pfaff SL. The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron. 2007;56:604&#x2013;620. doi: 10.1016/j.neuron.2007.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.09.009</ArticleId><ArticleId IdType="pubmed">18031680</ArticleId></ArticleIdList></Reference><Reference><Citation>Po MD, Hwang C, Zhen M. PHRs: bridging axon guidance, outgrowth and synapse development. Curr Opin Neurobiol. 2010;20:100&#x2013;107. doi: 10.1016/j.neuron.2007.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.09.009</ArticleId><ArticleId IdType="pubmed">20079626</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P, Moreno J, Aso E, Povedano M, Ferrer I. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY) 2017;9:823&#x2013;851. doi: 10.18632/aging.101195.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101195</ArticleId><ArticleId IdType="pmc">PMC5391234</ArticleId><ArticleId IdType="pubmed">28283675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman BJ, Hoffman EP, Sutherland ML, Bouri K, Hsu DK, Liu F-T, Rothstein JD, Knoblach SM. Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Behav. 2012;2:563&#x2013;575. doi: 10.1002/brb3.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.75</ArticleId><ArticleId IdType="pmc">PMC3489809</ArticleId><ArticleId IdType="pubmed">23139902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, Peng J. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J Proteome Res. 2010;9:5133&#x2013;5141. doi: 10.1021/pr100409r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr100409r</ArticleId><ArticleId IdType="pmc">PMC2948604</ArticleId><ArticleId IdType="pubmed">20698585</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorgerd M, Van Der Ven PFM, Bruchertseifer V, L&#xf6;we T, Kley RA, Schr&#xf6;der R, Lochm&#xfc;ller H, Himmel M, Koehler K, F&#xfc;rst DO, Huebner A. A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet. 2005;77:297&#x2013;304. doi: 10.1086/431959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/431959</ArticleId><ArticleId IdType="pmc">PMC1224531</ArticleId><ArticleId IdType="pubmed">15929027</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff RM, Tay V, Hackman P, Ravenscroft G, McLean C, Kennedy P, Steinbach A, Sch&#xf6;ffler W, Van Der Ven PFM, F&#xfc;rst DO, Song J, Djinovi&#x107;-Carugo K, Penttil&#xe4; S, Raheem O, Reardon K, Malandrini A, Gambelli S, Villanova M, Nowak KJ, Williams DR, Landers JE, Brown RH, Udd B, Laing NG. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet. 2011;88:729&#x2013;740. doi: 10.1016/j.ajhg.2011.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.04.021</ArticleId><ArticleId IdType="pmc">PMC3113346</ArticleId><ArticleId IdType="pubmed">21620354</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid B, Hruscha A, Hogl S, Banzhaf-Strathmann J, Strecker K, Van Der Zee J, Teucke M, Eimer S, Hegermann J, Kittelmann M, Kremmer E, Cruts M, Solchenberger B, Hasenkamp L, Van Bebber F, Van Broeckhoven C, Edbauer D, Lichtenthaler SF, Haass C. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A. 2013;110:4986&#x2013;4991. doi: 10.1073/pnas.1218311110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218311110</ArticleId><ArticleId IdType="pmc">PMC3612625</ArticleId><ArticleId IdType="pubmed">23457265</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu CI, Woehlbier U, Torres M, Hetz C. Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications. FEBS Lett. 2012;586:2826&#x2013;2834. doi: 10.1016/j.febslet.2012.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2012.07.023</ArticleId><ArticleId IdType="pubmed">22828277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon G, Nakamura T, Lee J-S, Choi W-J, Ahn S-W, Lee K-W, Sung J-J, Lipton SA. Potential effect of S-nitrosylated protein disulfide isomerase on mutant SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis. Mol Neurobiol. 2014;49:796&#x2013;807. doi: 10.1007/s12035-013-8562-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8562-z</ArticleId><ArticleId IdType="pmc">PMC5973792</ArticleId><ArticleId IdType="pubmed">24091828</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehara T, Nakamura T, Yao D, Shi Z-Q, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006;441:513&#x2013;517. doi: 10.1038/nature04782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04782</ArticleId><ArticleId IdType="pubmed">16724068</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Farg MA, Bye CR, McLean CA, Horne MK, Atkin JD. Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain. 2010;133:105&#x2013;116. doi: 10.1093/brain/awp267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp267</ArticleId><ArticleId IdType="pubmed">19903735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhang X, Li C, Guan T, Shang H, Cui L, Li X-M, Kong J. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis. J Neurochem. 2013;124:45&#x2013;58. doi: 10.1111/jnc.12046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12046</ArticleId><ArticleId IdType="pubmed">23043510</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliaga L, Lai C, Yu J, Chub N, Shim H, Sun L, Xie C, Yang W-J, Lin X, O&#x2019;Donovan MJ, Cai H. Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum Mol Genet. 2013;22:4293&#x2013;4305. doi: 10.1093/hmg/ddt279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt279</ArticleId><ArticleId IdType="pmc">PMC3792689</ArticleId><ArticleId IdType="pubmed">23771029</ArticleId></ArticleIdList></Reference><Reference><Citation>Honjo Y, Kaneko S, Ito H, Horibe T, Nagashima M, Nakamura M, Fujita K, Takahashi R, Kusaka H, Kawakami K. Protein disulfide isomerase-immunopositive inclusions in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:444&#x2013;450. doi: 10.3109/17482968.2011.594055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.594055</ArticleId><ArticleId IdType="pubmed">21745122</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Soo KY, Walker AK, Pham H, Orian J, Horne MK, Warraich ST, Williams KL, Blair IP, Atkin JD. Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol Aging. 2012;33:2855&#x2013;2868. doi: 10.1016/j.neurobiolaging.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.02.009</ArticleId><ArticleId IdType="pubmed">22459602</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Chem Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirren E, Aebischer J, Rochat C, Towne C, Schneider BL, Aebischer P. SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice. Ann Clin Transl Neurol. 2015;2:167&#x2013;184. doi: 10.1002/acn3.162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.162</ArticleId><ArticleId IdType="pmc">PMC4338957</ArticleId><ArticleId IdType="pubmed">25750921</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I, Monta&#xf1;ana-Rosell R, Selvan R, L&#xf6;w P, Kiehn O (2020) Locomotor deficits in ALS mice are paralleled by loss of V1-interneuron-connections onto fast motor neurons. bioRxiv 2020.06.23.166389. 10.1101/2020.06.23.166389</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.23.166389v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J, Aguzzi A. Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci. 2010;13:310&#x2013;318. doi: 10.1038/nn.2483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2483</ArticleId><ArticleId IdType="pubmed">20098419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall GNM, Lopes MH, Mercadante MAF, Velga SS, da Silveira RB, Santos TG, Ribeiro KCB, Juliano MA, Jacchieri SG, Zanata SM, Martins VR. Cellular prion protein interaction with vitronectin supports axonol growth and is compensated by integrins. J Cell Sci. 2007;120:1915&#x2013;1926. doi: 10.1242/jcs.03459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.03459</ArticleId><ArticleId IdType="pubmed">17504807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>